Alta Schutte: Delivery Models to Improve Adherence to Medicines for Chronic Diseases in Primary Care
Alta Schutte, SHARP Professor of Cardiovascular Medicine at University of New South Wales, shared on LinkedIn:
“If we can improve how medicines are delivered, medication adherence may be significantly improved. In our The Lancet Primary Care paper we highlight and compare the pros and cons of in-person pharmacy pickup, mail-order pharmacies, e-Pharmacies and direct-to-consumer models, emerging tech like drones, kiosks and physician dispensing vary in terms of cost-efficiency and scalability. We compare the models of delivery across 31 countries and how these models are diversified across the world. Lots of lessons to be learnt from innovative low-resource settings.
Great to work with Romina Ruth Diaz, Gautam Satheesh, Pablo Perel, Andrew Moran and Anthony Rodgers.”
Title: Delivery models to improve adherence to medicines for chronic diseases in primary care
Authors: Romina R Diaz, Gautam Satheesh, Andrew E Moran, Pablo Perel, Anthony Rodgers, Aletta E Schutte

Read the full paper on The Lancet Primary Care.
Find more on Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk